Skip to main content

Table 1 Characteristics of patients with and without AKI

From: Biomarker enhanced risk prediction for development of AKI after cardiac surgery

 

AKI (15)

No AKI (32)

P value

Age

68 ± 11

67 ± 11

0.72

Male:Female

9:7

21:14

0.61

White:Black

11:4

29:5

0.20

Risk Factor Score

7.1 ±1.5

5.9 ± 1.1

0.005

CHF

8 (53)

25 (78)

0.083

DM

8 (53)

18 (56)

0.85

COPD

4 (27)

13 (41)

0.44

CKD

12 (80)

17 (53)

0.12

HTN

15 (100)

25 (78)

0.068

CVA

2 (13)

3 (9.4)

0.71

PVD

1 (6.7)

4 (13)

0.50

Pre-Op Creatinine (mg/dl)

2.1 ± 0.72

1.4 ± 0.59

0.002

Peak Creatinine (mg/dl)

3.4 ± 1.14

1.7 ± 0.62

<0.001

ACEI/ARB

3

16

0.026

Pre-Op SBP (mm/Hg)

141 ± 28

140 ± 21

0.91

Pre-Op DBP (mm/Hg)

78 ± 18.2

76 ± 13

0.71

6 hr SBP (mm/Hg)

106 ± 16

112 ± 16

0.25

6 hr DBP (mm/Hg)

51 ± 10

58 ± 21

0.23

CABG:valve:both

4:4:6

5:18:9

0.24

Urine Output 1st 6 hr (ml)

444 ± 352

518± 223

0.40

Urine Output 1st 24 hr (ml)

1256 ± 598

1567 ± 821

0.21

AKI Stage 1/2/3

13/2/0

  
  1. CHF congestive heart failure; DM diabetes mellitus; COPD chronic obstructive pulmonary disease; CKD chronic kidney disease; HTN hypertension; CVA cerebrovascular accident; PVD peripheral vascular disease; ACEI angiotensin converting enzyme inhibitor; ARB angiotensin receptor blocker; SBP systolic blood pressure; DBP diastolic blood pressure; CABG coronary artery bypass graft